Abstract:Objective To compare the clinical effect of small bone window craniotomy and large bone flap craniotomy in the treatment of hypertensive intracerebral hemorrhage.Methods 90 patients with hypertensive intracerebral hemorrhage admitted into our hospital from March 2013 to March 2016 were selected as the study subjects.The patients were randomly divided into the control group and the study group,and there were 45 cases in each group and they were respectively given traditional large bone flap craniotomy and small bone window craniotomy.The incision length,intraoperative blood loss,postoperative cerebrospinal fluid leakage,operation time,average length of hospital stay and the incidence rate of postoperative complications were compared between the two groups.Results The incision length,operation time and average length of stay in the study group were significantly shorter than those in the control group,and the difference was statistically significant(P<0.05).The intraoperative blood loss in the study group was significantly lower than that in the control group(P<0.05).The total clinical effective rate in the study group was 91.11%,which was significantly higher than that of 71.11%in the control group,and the difference was statistically significant(P<0.05).The incidence rate of total complications was 15.56%,which was significantly better than the control group(42.22%),and the difference was statistically significant(P<0.05).Conclusion Small bone window craniotomy and traditional large bone flap craniotomy can both effectively treat the hypertensive intracerebral hemorrhage,but compared with large bone flap craniotomy,small bone window craniotomy has a good clinical efficacy.The trauma is small,the operation time is short,the incidence of postoperative complications and mortality are low,and it is safe and reliable.
许金发;庄义杰;郑雁旋. 小骨窗开颅术与大骨瓣开颅术治疗高血压脑出血的效果对比[J]. 中国当代医药, 2017, 24(28): 73-75.
XU Jin-fa;ZHUANG Yi-jie;ZHENG Yan-xuan. Effect comparison of small bone window craniotomy and large bone flap craniotomy in the treatment of hypertensive intracerebral hemorrhage. 中国当代医药, 2017, 24(28): 73-75.